AcouSort AB (publ) (STO:ACOU)
2.540
-0.090 (-3.42%)
Jan 21, 2026, 4:35 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 55.66 million as of January 21, 2026. Its market cap has decreased by -66.12% in one year.
Market Cap
55.66M
Enterprise Value
43.83M
Revenue
10.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.54
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has decreased from 65.36M to 55.66M, a decrease of -14.84%. That is a compound annual growth rate of -1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 55.66M | -7.07% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 85.67M |
| Karolinska Development AB | 83.65M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 78.24M |
| OncoZenge AB | 77.02M |
| Nanologica AB | 61.33M |
| ExpreS2ion Biotech Holding AB | 54.29M |
| Guard Therapeutics International AB | 43.16M |